PHARMACOLOGICAL RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2114583, encodeId=21bd211458316, content=想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Tue Feb 14 15:50:55 CST 2023, time=2023-02-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115186, encodeId=c2662115186af, content=IF还能保住10吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/09/f552e9077f6eb10d966d8984e912ef3c.jpg, createdBy=c32179224, createdName=xzj1322007, createdTime=Sat Feb 18 01:12:05 CST 2023, time=2023-02-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126595, encodeId=9227212659587, content=投稿第二天就变成decession in process，结果又等了四天还没有收到拒稿信。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49bb6565860, createdName=ms7000000230836793, createdTime=Mon Apr 17 21:47:18 CST 2023, time=2023-04-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2121689, encodeId=bfd321216892c, content=请问有人知道这个杂志的checklist在哪下载原件吗? 投稿要填写找半天没看见呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5ca2287978, createdName=博莱霉素, createdTime=Fri Mar 24 23:38:05 CST 2023, time=2023-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123274, encodeId=c3b821232e4aa, content=请问各位大佬，投稿该杂志时，文章的查重率都控制在什么范围呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14686157349, createdName=ms8000000734596950, createdTime=Sun Apr 02 15:03:01 CST 2023, time=2023-04-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1243301, encodeId=47f012433012a, content=请问友友们，这个杂志接收meta分析嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65706579694, createdName=ms6000000442592867, createdTime=Mon Sep 05 14:11:05 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575789, encodeId=86875e578987, content=请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, beContent=SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7735160960, createdName=letitia, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109030, encodeId=918321090300b, content=偏重的研究方向：机制;靶向治疗;药理 经验分享：2022.12.09晚提交 2022.12.10晚被拒，但是评价不错，让补体内实验重投 2022.12.14体内实验补完，重投回去， submit to journal 2022.12.15 with editor 2022.12.20 under review 2022.12.29 required reviews completed 2023.01.03 under review 祈祷好运[合十][合十][合十], beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70838451007, createdName=ms9000001669050818, createdTime=Fri Jan 06 09:29:11 CST 2023, time=2023-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104045, encodeId=413e21040454b, content=偏重的研究方向：中药 经验分享：投稿两天后要我转投他的姐妹杂志。。。decision ： Research - Modern Chinese Medicine, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e468439140, createdName=ms9000001887224595, createdTime=Sat Dec 03 09:25:45 CST 2022, time=2022-12-03, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2106882, encodeId=0deb2106882a4, content=大佬们，2022年这杂志几区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d935707939, createdName=ms7000000249495571, createdTime=Wed Dec 21 09:02:40 CST 2022, time=2022-12-21, status=1, ipAttribution=广东省)]

2023-02-14 FPW 来自江苏省

想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？

32 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114583, encodeId=21bd211458316, content=想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Tue Feb 14 15:50:55 CST 2023, time=2023-02-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115186, encodeId=c2662115186af, content=IF还能保住10吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/09/f552e9077f6eb10d966d8984e912ef3c.jpg, createdBy=c32179224, createdName=xzj1322007, createdTime=Sat Feb 18 01:12:05 CST 2023, time=2023-02-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126595, encodeId=9227212659587, content=投稿第二天就变成decession in process，结果又等了四天还没有收到拒稿信。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49bb6565860, createdName=ms7000000230836793, createdTime=Mon Apr 17 21:47:18 CST 2023, time=2023-04-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2121689, encodeId=bfd321216892c, content=请问有人知道这个杂志的checklist在哪下载原件吗? 投稿要填写找半天没看见呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5ca2287978, createdName=博莱霉素, createdTime=Fri Mar 24 23:38:05 CST 2023, time=2023-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123274, encodeId=c3b821232e4aa, content=请问各位大佬，投稿该杂志时，文章的查重率都控制在什么范围呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14686157349, createdName=ms8000000734596950, createdTime=Sun Apr 02 15:03:01 CST 2023, time=2023-04-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1243301, encodeId=47f012433012a, content=请问友友们，这个杂志接收meta分析嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65706579694, createdName=ms6000000442592867, createdTime=Mon Sep 05 14:11:05 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575789, encodeId=86875e578987, content=请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, beContent=SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7735160960, createdName=letitia, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109030, encodeId=918321090300b, content=偏重的研究方向：机制;靶向治疗;药理 经验分享：2022.12.09晚提交 2022.12.10晚被拒，但是评价不错，让补体内实验重投 2022.12.14体内实验补完，重投回去， submit to journal 2022.12.15 with editor 2022.12.20 under review 2022.12.29 required reviews completed 2023.01.03 under review 祈祷好运[合十][合十][合十], beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70838451007, createdName=ms9000001669050818, createdTime=Fri Jan 06 09:29:11 CST 2023, time=2023-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104045, encodeId=413e21040454b, content=偏重的研究方向：中药 经验分享：投稿两天后要我转投他的姐妹杂志。。。decision ： Research - Modern Chinese Medicine, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e468439140, createdName=ms9000001887224595, createdTime=Sat Dec 03 09:25:45 CST 2022, time=2022-12-03, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2106882, encodeId=0deb2106882a4, content=大佬们，2022年这杂志几区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d935707939, createdName=ms7000000249495571, createdTime=Wed Dec 21 09:02:40 CST 2022, time=2022-12-21, status=1, ipAttribution=广东省)]

2023-02-18 xzj1322007 来自湖南省

IF还能保住10吗？

40 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114583, encodeId=21bd211458316, content=想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Tue Feb 14 15:50:55 CST 2023, time=2023-02-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115186, encodeId=c2662115186af, content=IF还能保住10吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/09/f552e9077f6eb10d966d8984e912ef3c.jpg, createdBy=c32179224, createdName=xzj1322007, createdTime=Sat Feb 18 01:12:05 CST 2023, time=2023-02-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126595, encodeId=9227212659587, content=投稿第二天就变成decession in process，结果又等了四天还没有收到拒稿信。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49bb6565860, createdName=ms7000000230836793, createdTime=Mon Apr 17 21:47:18 CST 2023, time=2023-04-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2121689, encodeId=bfd321216892c, content=请问有人知道这个杂志的checklist在哪下载原件吗? 投稿要填写找半天没看见呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5ca2287978, createdName=博莱霉素, createdTime=Fri Mar 24 23:38:05 CST 2023, time=2023-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123274, encodeId=c3b821232e4aa, content=请问各位大佬，投稿该杂志时，文章的查重率都控制在什么范围呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14686157349, createdName=ms8000000734596950, createdTime=Sun Apr 02 15:03:01 CST 2023, time=2023-04-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1243301, encodeId=47f012433012a, content=请问友友们，这个杂志接收meta分析嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65706579694, createdName=ms6000000442592867, createdTime=Mon Sep 05 14:11:05 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575789, encodeId=86875e578987, content=请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, beContent=SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7735160960, createdName=letitia, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109030, encodeId=918321090300b, content=偏重的研究方向：机制;靶向治疗;药理 经验分享：2022.12.09晚提交 2022.12.10晚被拒，但是评价不错，让补体内实验重投 2022.12.14体内实验补完，重投回去， submit to journal 2022.12.15 with editor 2022.12.20 under review 2022.12.29 required reviews completed 2023.01.03 under review 祈祷好运[合十][合十][合十], beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70838451007, createdName=ms9000001669050818, createdTime=Fri Jan 06 09:29:11 CST 2023, time=2023-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104045, encodeId=413e21040454b, content=偏重的研究方向：中药 经验分享：投稿两天后要我转投他的姐妹杂志。。。decision ： Research - Modern Chinese Medicine, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e468439140, createdName=ms9000001887224595, createdTime=Sat Dec 03 09:25:45 CST 2022, time=2022-12-03, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2106882, encodeId=0deb2106882a4, content=大佬们，2022年这杂志几区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d935707939, createdName=ms7000000249495571, createdTime=Wed Dec 21 09:02:40 CST 2022, time=2022-12-21, status=1, ipAttribution=广东省)]

2023-04-17 ms7000000230836793 来自湖北省

投稿第二天就变成decession in process，结果又等了四天还没有收到拒稿信。。。。。

1 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114583, encodeId=21bd211458316, content=想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Tue Feb 14 15:50:55 CST 2023, time=2023-02-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115186, encodeId=c2662115186af, content=IF还能保住10吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/09/f552e9077f6eb10d966d8984e912ef3c.jpg, createdBy=c32179224, createdName=xzj1322007, createdTime=Sat Feb 18 01:12:05 CST 2023, time=2023-02-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126595, encodeId=9227212659587, content=投稿第二天就变成decession in process，结果又等了四天还没有收到拒稿信。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49bb6565860, createdName=ms7000000230836793, createdTime=Mon Apr 17 21:47:18 CST 2023, time=2023-04-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2121689, encodeId=bfd321216892c, content=请问有人知道这个杂志的checklist在哪下载原件吗? 投稿要填写找半天没看见呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5ca2287978, createdName=博莱霉素, createdTime=Fri Mar 24 23:38:05 CST 2023, time=2023-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123274, encodeId=c3b821232e4aa, content=请问各位大佬，投稿该杂志时，文章的查重率都控制在什么范围呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14686157349, createdName=ms8000000734596950, createdTime=Sun Apr 02 15:03:01 CST 2023, time=2023-04-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1243301, encodeId=47f012433012a, content=请问友友们，这个杂志接收meta分析嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65706579694, createdName=ms6000000442592867, createdTime=Mon Sep 05 14:11:05 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575789, encodeId=86875e578987, content=请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, beContent=SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7735160960, createdName=letitia, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109030, encodeId=918321090300b, content=偏重的研究方向：机制;靶向治疗;药理 经验分享：2022.12.09晚提交 2022.12.10晚被拒，但是评价不错，让补体内实验重投 2022.12.14体内实验补完，重投回去， submit to journal 2022.12.15 with editor 2022.12.20 under review 2022.12.29 required reviews completed 2023.01.03 under review 祈祷好运[合十][合十][合十], beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70838451007, createdName=ms9000001669050818, createdTime=Fri Jan 06 09:29:11 CST 2023, time=2023-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104045, encodeId=413e21040454b, content=偏重的研究方向：中药 经验分享：投稿两天后要我转投他的姐妹杂志。。。decision ： Research - Modern Chinese Medicine, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e468439140, createdName=ms9000001887224595, createdTime=Sat Dec 03 09:25:45 CST 2022, time=2022-12-03, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2106882, encodeId=0deb2106882a4, content=大佬们，2022年这杂志几区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d935707939, createdName=ms7000000249495571, createdTime=Wed Dec 21 09:02:40 CST 2022, time=2022-12-21, status=1, ipAttribution=广东省)]

2023-03-24 博莱霉素来自湖北省

请问有人知道这个杂志的checklist在哪下载原件吗? 投稿要填写找半天没看见呀

48 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114583, encodeId=21bd211458316, content=想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Tue Feb 14 15:50:55 CST 2023, time=2023-02-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115186, encodeId=c2662115186af, content=IF还能保住10吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/09/f552e9077f6eb10d966d8984e912ef3c.jpg, createdBy=c32179224, createdName=xzj1322007, createdTime=Sat Feb 18 01:12:05 CST 2023, time=2023-02-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126595, encodeId=9227212659587, content=投稿第二天就变成decession in process，结果又等了四天还没有收到拒稿信。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49bb6565860, createdName=ms7000000230836793, createdTime=Mon Apr 17 21:47:18 CST 2023, time=2023-04-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2121689, encodeId=bfd321216892c, content=请问有人知道这个杂志的checklist在哪下载原件吗? 投稿要填写找半天没看见呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5ca2287978, createdName=博莱霉素, createdTime=Fri Mar 24 23:38:05 CST 2023, time=2023-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123274, encodeId=c3b821232e4aa, content=请问各位大佬，投稿该杂志时，文章的查重率都控制在什么范围呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14686157349, createdName=ms8000000734596950, createdTime=Sun Apr 02 15:03:01 CST 2023, time=2023-04-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1243301, encodeId=47f012433012a, content=请问友友们，这个杂志接收meta分析嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65706579694, createdName=ms6000000442592867, createdTime=Mon Sep 05 14:11:05 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575789, encodeId=86875e578987, content=请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, beContent=SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7735160960, createdName=letitia, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109030, encodeId=918321090300b, content=偏重的研究方向：机制;靶向治疗;药理 经验分享：2022.12.09晚提交 2022.12.10晚被拒，但是评价不错，让补体内实验重投 2022.12.14体内实验补完，重投回去， submit to journal 2022.12.15 with editor 2022.12.20 under review 2022.12.29 required reviews completed 2023.01.03 under review 祈祷好运[合十][合十][合十], beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70838451007, createdName=ms9000001669050818, createdTime=Fri Jan 06 09:29:11 CST 2023, time=2023-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104045, encodeId=413e21040454b, content=偏重的研究方向：中药 经验分享：投稿两天后要我转投他的姐妹杂志。。。decision ： Research - Modern Chinese Medicine, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e468439140, createdName=ms9000001887224595, createdTime=Sat Dec 03 09:25:45 CST 2022, time=2022-12-03, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2106882, encodeId=0deb2106882a4, content=大佬们，2022年这杂志几区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d935707939, createdName=ms7000000249495571, createdTime=Wed Dec 21 09:02:40 CST 2022, time=2022-12-21, status=1, ipAttribution=广东省)]

2023-04-02 ms8000000734596950 来自广西

请问各位大佬，投稿该杂志时，文章的查重率都控制在什么范围呀

38 0

[GetPortalCommentsPageByObjectIdResponse(id=2114583, encodeId=21bd211458316, content=想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Tue Feb 14 15:50:55 CST 2023, time=2023-02-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115186, encodeId=c2662115186af, content=IF还能保住10吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/09/f552e9077f6eb10d966d8984e912ef3c.jpg, createdBy=c32179224, createdName=xzj1322007, createdTime=Sat Feb 18 01:12:05 CST 2023, time=2023-02-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126595, encodeId=9227212659587, content=投稿第二天就变成decession in process，结果又等了四天还没有收到拒稿信。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49bb6565860, createdName=ms7000000230836793, createdTime=Mon Apr 17 21:47:18 CST 2023, time=2023-04-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2121689, encodeId=bfd321216892c, content=请问有人知道这个杂志的checklist在哪下载原件吗? 投稿要填写找半天没看见呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5ca2287978, createdName=博莱霉素, createdTime=Fri Mar 24 23:38:05 CST 2023, time=2023-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123274, encodeId=c3b821232e4aa, content=请问各位大佬，投稿该杂志时，文章的查重率都控制在什么范围呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14686157349, createdName=ms8000000734596950, createdTime=Sun Apr 02 15:03:01 CST 2023, time=2023-04-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1243301, encodeId=47f012433012a, content=请问友友们，这个杂志接收meta分析嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65706579694, createdName=ms6000000442592867, createdTime=Mon Sep 05 14:11:05 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575789, encodeId=86875e578987, content=请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, beContent=SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7735160960, createdName=letitia, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109030, encodeId=918321090300b, content=偏重的研究方向：机制;靶向治疗;药理 经验分享：2022.12.09晚提交 2022.12.10晚被拒，但是评价不错，让补体内实验重投 2022.12.14体内实验补完，重投回去， submit to journal 2022.12.15 with editor 2022.12.20 under review 2022.12.29 required reviews completed 2023.01.03 under review 祈祷好运[合十][合十][合十], beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70838451007, createdName=ms9000001669050818, createdTime=Fri Jan 06 09:29:11 CST 2023, time=2023-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104045, encodeId=413e21040454b, content=偏重的研究方向：中药 经验分享：投稿两天后要我转投他的姐妹杂志。。。decision ： Research - Modern Chinese Medicine, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e468439140, createdName=ms9000001887224595, createdTime=Sat Dec 03 09:25:45 CST 2022, time=2022-12-03, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2106882, encodeId=0deb2106882a4, content=大佬们，2022年这杂志几区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d935707939, createdName=ms7000000249495571, createdTime=Wed Dec 21 09:02:40 CST 2022, time=2022-12-21, status=1, ipAttribution=广东省)]

2022-09-05 ms6000000442592867

请问友友们，这个杂志接收meta分析嘛

41 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114583, encodeId=21bd211458316, content=想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Tue Feb 14 15:50:55 CST 2023, time=2023-02-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115186, encodeId=c2662115186af, content=IF还能保住10吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/09/f552e9077f6eb10d966d8984e912ef3c.jpg, createdBy=c32179224, createdName=xzj1322007, createdTime=Sat Feb 18 01:12:05 CST 2023, time=2023-02-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126595, encodeId=9227212659587, content=投稿第二天就变成decession in process，结果又等了四天还没有收到拒稿信。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49bb6565860, createdName=ms7000000230836793, createdTime=Mon Apr 17 21:47:18 CST 2023, time=2023-04-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2121689, encodeId=bfd321216892c, content=请问有人知道这个杂志的checklist在哪下载原件吗? 投稿要填写找半天没看见呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5ca2287978, createdName=博莱霉素, createdTime=Fri Mar 24 23:38:05 CST 2023, time=2023-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123274, encodeId=c3b821232e4aa, content=请问各位大佬，投稿该杂志时，文章的查重率都控制在什么范围呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14686157349, createdName=ms8000000734596950, createdTime=Sun Apr 02 15:03:01 CST 2023, time=2023-04-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1243301, encodeId=47f012433012a, content=请问友友们，这个杂志接收meta分析嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65706579694, createdName=ms6000000442592867, createdTime=Mon Sep 05 14:11:05 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575789, encodeId=86875e578987, content=请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, beContent=SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7735160960, createdName=letitia, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109030, encodeId=918321090300b, content=偏重的研究方向：机制;靶向治疗;药理 经验分享：2022.12.09晚提交 2022.12.10晚被拒，但是评价不错，让补体内实验重投 2022.12.14体内实验补完，重投回去， submit to journal 2022.12.15 with editor 2022.12.20 under review 2022.12.29 required reviews completed 2023.01.03 under review 祈祷好运[合十][合十][合十], beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70838451007, createdName=ms9000001669050818, createdTime=Fri Jan 06 09:29:11 CST 2023, time=2023-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104045, encodeId=413e21040454b, content=偏重的研究方向：中药 经验分享：投稿两天后要我转投他的姐妹杂志。。。decision ： Research - Modern Chinese Medicine, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e468439140, createdName=ms9000001887224595, createdTime=Sat Dec 03 09:25:45 CST 2022, time=2022-12-03, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2106882, encodeId=0deb2106882a4, content=大佬们，2022年这杂志几区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d935707939, createdName=ms7000000249495571, createdTime=Wed Dec 21 09:02:40 CST 2022, time=2022-12-21, status=1, ipAttribution=广东省)]

2019-09-03 letitia

请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表:
我上传了平行的三次结果，大部分结果的marker可见。

SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。

148 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114583, encodeId=21bd211458316, content=想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Tue Feb 14 15:50:55 CST 2023, time=2023-02-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115186, encodeId=c2662115186af, content=IF还能保住10吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/09/f552e9077f6eb10d966d8984e912ef3c.jpg, createdBy=c32179224, createdName=xzj1322007, createdTime=Sat Feb 18 01:12:05 CST 2023, time=2023-02-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126595, encodeId=9227212659587, content=投稿第二天就变成decession in process，结果又等了四天还没有收到拒稿信。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49bb6565860, createdName=ms7000000230836793, createdTime=Mon Apr 17 21:47:18 CST 2023, time=2023-04-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2121689, encodeId=bfd321216892c, content=请问有人知道这个杂志的checklist在哪下载原件吗? 投稿要填写找半天没看见呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5ca2287978, createdName=博莱霉素, createdTime=Fri Mar 24 23:38:05 CST 2023, time=2023-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123274, encodeId=c3b821232e4aa, content=请问各位大佬，投稿该杂志时，文章的查重率都控制在什么范围呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14686157349, createdName=ms8000000734596950, createdTime=Sun Apr 02 15:03:01 CST 2023, time=2023-04-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1243301, encodeId=47f012433012a, content=请问友友们，这个杂志接收meta分析嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65706579694, createdName=ms6000000442592867, createdTime=Mon Sep 05 14:11:05 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575789, encodeId=86875e578987, content=请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, beContent=SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7735160960, createdName=letitia, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109030, encodeId=918321090300b, content=偏重的研究方向：机制;靶向治疗;药理 经验分享：2022.12.09晚提交 2022.12.10晚被拒，但是评价不错，让补体内实验重投 2022.12.14体内实验补完，重投回去， submit to journal 2022.12.15 with editor 2022.12.20 under review 2022.12.29 required reviews completed 2023.01.03 under review 祈祷好运[合十][合十][合十], beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70838451007, createdName=ms9000001669050818, createdTime=Fri Jan 06 09:29:11 CST 2023, time=2023-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104045, encodeId=413e21040454b, content=偏重的研究方向：中药 经验分享：投稿两天后要我转投他的姐妹杂志。。。decision ： Research - Modern Chinese Medicine, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e468439140, createdName=ms9000001887224595, createdTime=Sat Dec 03 09:25:45 CST 2022, time=2022-12-03, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2106882, encodeId=0deb2106882a4, content=大佬们，2022年这杂志几区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d935707939, createdName=ms7000000249495571, createdTime=Wed Dec 21 09:02:40 CST 2022, time=2022-12-21, status=1, ipAttribution=广东省)]

2023-01-06 ms9000001669050818

偏重的研究方向：机制;靶向治疗;药理
经验分享：2022.12.09晚提交 2022.12.10晚被拒，但是评价不错，让补体内实验重投 2022.12.14体内实验补完，重投回去， submit to journal 2022.12.15 with editor 2022.12.20 under review 2022.12.29 required reviews completed 2023.01.03 under review 祈祷好运[合十][合十][合十]

47 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114583, encodeId=21bd211458316, content=想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Tue Feb 14 15:50:55 CST 2023, time=2023-02-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115186, encodeId=c2662115186af, content=IF还能保住10吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/09/f552e9077f6eb10d966d8984e912ef3c.jpg, createdBy=c32179224, createdName=xzj1322007, createdTime=Sat Feb 18 01:12:05 CST 2023, time=2023-02-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126595, encodeId=9227212659587, content=投稿第二天就变成decession in process，结果又等了四天还没有收到拒稿信。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49bb6565860, createdName=ms7000000230836793, createdTime=Mon Apr 17 21:47:18 CST 2023, time=2023-04-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2121689, encodeId=bfd321216892c, content=请问有人知道这个杂志的checklist在哪下载原件吗? 投稿要填写找半天没看见呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5ca2287978, createdName=博莱霉素, createdTime=Fri Mar 24 23:38:05 CST 2023, time=2023-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123274, encodeId=c3b821232e4aa, content=请问各位大佬，投稿该杂志时，文章的查重率都控制在什么范围呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14686157349, createdName=ms8000000734596950, createdTime=Sun Apr 02 15:03:01 CST 2023, time=2023-04-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1243301, encodeId=47f012433012a, content=请问友友们，这个杂志接收meta分析嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65706579694, createdName=ms6000000442592867, createdTime=Mon Sep 05 14:11:05 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575789, encodeId=86875e578987, content=请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, beContent=SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7735160960, createdName=letitia, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109030, encodeId=918321090300b, content=偏重的研究方向：机制;靶向治疗;药理 经验分享：2022.12.09晚提交 2022.12.10晚被拒，但是评价不错，让补体内实验重投 2022.12.14体内实验补完，重投回去， submit to journal 2022.12.15 with editor 2022.12.20 under review 2022.12.29 required reviews completed 2023.01.03 under review 祈祷好运[合十][合十][合十], beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70838451007, createdName=ms9000001669050818, createdTime=Fri Jan 06 09:29:11 CST 2023, time=2023-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104045, encodeId=413e21040454b, content=偏重的研究方向：中药 经验分享：投稿两天后要我转投他的姐妹杂志。。。decision ： Research - Modern Chinese Medicine, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e468439140, createdName=ms9000001887224595, createdTime=Sat Dec 03 09:25:45 CST 2022, time=2022-12-03, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2106882, encodeId=0deb2106882a4, content=大佬们，2022年这杂志几区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d935707939, createdName=ms7000000249495571, createdTime=Wed Dec 21 09:02:40 CST 2022, time=2022-12-21, status=1, ipAttribution=广东省)]

2022-12-03 ms9000001887224595 来自江西省

偏重的研究方向：中药
经验分享：投稿两天后要我转投他的姐妹杂志。。。decision ： Research - Modern Chinese Medicine

48 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114583, encodeId=21bd211458316, content=想问下OA文章要版面费吗？接收了已经一阵子了，杂志社还没问要版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Tue Feb 14 15:50:55 CST 2023, time=2023-02-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115186, encodeId=c2662115186af, content=IF还能保住10吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/09/f552e9077f6eb10d966d8984e912ef3c.jpg, createdBy=c32179224, createdName=xzj1322007, createdTime=Sat Feb 18 01:12:05 CST 2023, time=2023-02-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126595, encodeId=9227212659587, content=投稿第二天就变成decession in process，结果又等了四天还没有收到拒稿信。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49bb6565860, createdName=ms7000000230836793, createdTime=Mon Apr 17 21:47:18 CST 2023, time=2023-04-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2121689, encodeId=bfd321216892c, content=请问有人知道这个杂志的checklist在哪下载原件吗? 投稿要填写找半天没看见呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5ca2287978, createdName=博莱霉素, createdTime=Fri Mar 24 23:38:05 CST 2023, time=2023-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123274, encodeId=c3b821232e4aa, content=请问各位大佬，投稿该杂志时，文章的查重率都控制在什么范围呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14686157349, createdName=ms8000000734596950, createdTime=Sun Apr 02 15:03:01 CST 2023, time=2023-04-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1243301, encodeId=47f012433012a, content=请问友友们，这个杂志接收meta分析嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65706579694, createdName=ms6000000442592867, createdTime=Mon Sep 05 14:11:05 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575789, encodeId=86875e578987, content=请问下我的wb原图上没有marker？是不是不行？SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, beContent=SamuelWoo 2019-09-03 00:00:00 发表: 我上传了平行的三次结果，大部分结果的marker可见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7735160960, createdName=letitia, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109030, encodeId=918321090300b, content=偏重的研究方向：机制;靶向治疗;药理 经验分享：2022.12.09晚提交 2022.12.10晚被拒，但是评价不错，让补体内实验重投 2022.12.14体内实验补完，重投回去， submit to journal 2022.12.15 with editor 2022.12.20 under review 2022.12.29 required reviews completed 2023.01.03 under review 祈祷好运[合十][合十][合十], beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70838451007, createdName=ms9000001669050818, createdTime=Fri Jan 06 09:29:11 CST 2023, time=2023-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104045, encodeId=413e21040454b, content=偏重的研究方向：中药 经验分享：投稿两天后要我转投他的姐妹杂志。。。decision ： Research - Modern Chinese Medicine, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e468439140, createdName=ms9000001887224595, createdTime=Sat Dec 03 09:25:45 CST 2022, time=2022-12-03, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2106882, encodeId=0deb2106882a4, content=大佬们，2022年这杂志几区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d935707939, createdName=ms7000000249495571, createdTime=Wed Dec 21 09:02:40 CST 2022, time=2022-12-21, status=1, ipAttribution=广东省)]

2022-12-21 ms7000000249495571 来自广东省

大佬们，2022年这杂志几区

35 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务